Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle.

MLA

Dineen, Stacey L., et al. “Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle.” Diabetes, vol. 64, no. 9, Sept. 2015, pp. 3321–27. EBSCOhost, https://doi.org/10.2337/db14-1790.

APA

Dineen, S. L., McKenney, M. L., Bell, L. N., Fullenkamp, A. M., Schultz, K. A., Alloosh, M., Chalasani, N., & Sturek, M. (2015). Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle. Diabetes, 64(9), 3321–3327. https://doi.org/10.2337/db14-1790

Chicago

Dineen, Stacey L, Mikaela L McKenney, Lauren N Bell, Allison M Fullenkamp, Kyle A Schultz, Mouhamad Alloosh, Naga Chalasani, and Michael Sturek. 2015. “Metabolic Syndrome Abolishes Glucagon-Like Peptide 1 Receptor Agonist Stimulation of SERCA in Coronary Smooth Muscle.” Diabetes 64 (9): 3321–27. doi:10.2337/db14-1790.